PLoS ONE (Jan 2017)

Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability.

  • Marjory B Brooks,
  • James R Turk,
  • Abraham Guerrero,
  • Padma K Narayanan,
  • John P Nolan,
  • Elizabeth G Besteman,
  • Dennis W Wilson,
  • Roberta A Thomas,
  • Cindy E Fishman,
  • Karol L Thompson,
  • Heidrun Ellinger-Ziegelbauer,
  • Jennifer B Pierson,
  • April Paulman,
  • Alan Y Chiang,
  • Albert E Schultze

DOI
https://doi.org/10.1371/journal.pone.0169976
Journal volume & issue
Vol. 12, no. 1
p. e0169976

Abstract

Read online

Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance favoring hypercoagulability. Intraperitoneal injection of LPS at 15 mg/kg body weight resulted in peripheral leukopenia and widespread neutrophilic sequestration characteristic of an acute systemic inflammatory response. Early indicators of hemostatic pathway activation developed within 4 hours, including increased circulating concentrations of procoagulant extracellular vesicles (EVs), EVs expressing endothelial cell and platelet membrane markers, and high concentration of soluble intercellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1), and D-dimers. Inflammation persisted throughout the 48-hour observation period; however, increases were found in a subset of serum microRNA (miRNA) that coincided with gradual resolution of hemostatic protein abnormalities and reduction in EV counts. Dose-adjusted LPS treatment in rats provides a time-course model to develop biomarker profiles reflecting procoagulant imbalance and rebalance under inflammatory conditions.